Lesaffre, a global leader in fermentation and microorganisms, has announced the acquisition of a majority stake in Biorigin, a business unit of Zilor that specializes in yeast derivative products. This strategic move is aimed at strengthening Lesaffre’s position in the savory ingredients market, while enhancing production processes, logistics and customer service. Lesaffre now holds a 70% stake in Biorigin, while Zilor retains a 30% share.
The acquisition includes Biorigin's production unit located in Quatá, São Paulo, Brazil, a region rich in resources such as sugar, water and renewable energy, making it ideal for the production of yeast derivatives. The partnership will enable both companies to provide improved yeast-based solutions for the global food and animal nutrition markets.
Brice-Audren Riché, CEO of Lesaffre, expressed enthusiasm about the deal, stating, "This acquisition marks a significant step for Lesaffre in expanding our reach in the savory ingredients market. Together with Biorigin, we will be able to offer advanced yeast-derived solutions, meeting the increasing demand for natural, sustainable ingredients in human and animal nutrition."
Fabiano Zillo, CEO of Zilor, echoed this sentiment, highlighting Biorigin's 20-year history of innovation and sustainability. "Partnering with Lesaffre will allow us to further our mission and incorporate advanced R&D capabilities to better serve our customers and contribute to sustainable development."
Biorigin's brand and operations in yeast production will remain intact, with the company continuing to market its products independently. However, the expertise and resources from Lesaffre will bring additional growth opportunities for both companies.
The transaction is subject to regulatory approvals and is expected to be finalized in the coming months. During this period, both Lesaffre and Biorigin will continue to operate as independent entities.
